Prognostic relevance of the molecular classification in high-grade endometrial cancer for patients staged by lymphadenectomy and without adjuvant treatment
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic relevance of the molecular classification in high-grade endometrial cancer for patients staged by lymphadenectomy and without adjuvant treatment
Authors
Keywords
Endometrial cancer, Molecular risk factors, Lymphadenectomy, Lymphovascular space invasion
Journal
GYNECOLOGIC ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-01-23
DOI
10.1016/j.ygyno.2022.01.007
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta‐analysis
- (2021) Jessica N. McAlpine et al. CANCER
- Molecular subtypes of clear cell carcinoma of the endometrium: Opportunities for prognostic and predictive stratification
- (2020) Soyoun Rachel Kim et al. GYNECOLOGIC ONCOLOGY
- Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy
- (2020) Alicia León-Castillo et al. JOURNAL OF CLINICAL ONCOLOGY
- PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer
- (2020) Anne Sophie V M van den Heerik et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- PROGNOSTIC INTEGRATED IMAGE-BASED IMMUNE AND MOLECULAR PROFILING IN EARLY-STAGE ENDOMETRIAL CANCER
- (2020) Nanda Horeweg et al. Cancer Immunology Research
- ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
- (2020) Nicole Concin et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Location of recurrences in high-risk stage Iendometrial cancer patients not given postoperative radiotherapy: A Danish gynecological cancer group study
- (2019) Gitte Ørtoft et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer – a Swedish Gynecologic Cancer Group (SweGCG) study
- (2019) Karin Stålberg et al. ACTA ONCOLOGICA
- Incorporation of molecular characteristics into endometrial cancer management
- (2019) Lisa Vermij et al. HISTOPATHOLOGY
- p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies
- (2019) Naveena Singh et al. JOURNAL OF PATHOLOGY
- Interpretation of somatic POLE mutations in endometrial carcinoma
- (2019) Alicia León‐Castillo et al. JOURNAL OF PATHOLOGY
- Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups
- (2018) Tjalling Bosse et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series
- (2018) S Kommoss et al. ANNALS OF ONCOLOGY
- Adjuvant Treatment forPOLEProofreading Domain–Mutant Cancers: Sensitivity to Radiotherapy, Chemotherapy, and Nucleoside Analogues
- (2018) Inge C. Van Gool et al. CLINICAL CANCER RESEARCH
- Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy
- (2018) B. G. Wortman et al. BRITISH JOURNAL OF CANCER
- The genetic landscape of endometrial clear cell carcinomas
- (2017) Deborah F DeLair et al. JOURNAL OF PATHOLOGY
- A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study
- (2017) Emma C Rossi et al. LANCET ONCOLOGY
- L1CAM expression in endometrial carcinomas: an ENITEC collaboration study
- (2016) Louis JM van der Putten et al. BRITISH JOURNAL OF CANCER
- Endometrial Carcinomas with POLE Exonuclease Domain Mutations Have a Favorable Prognosis
- (2016) M. K. McConechy et al. CLINICAL CANCER RESEARCH
- Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts
- (2016) Ellen Stelloo et al. CLINICAL CANCER RESEARCH
- Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancer
- (2016) Inge C Van Gool et al. MODERN PATHOLOGY
- Danish Gynecological Cancer Database
- (2016) Sarah Soerensen et al. Clinical Epidemiology
- Neoepitopes and CD3-Positive and CD8-Positive Cells in Polymerase e–Mutated and Microsatellite-Instable Endometrial Cancers
- (2016) Inge C. van Gool et al. JAMA Oncology
- A clinically applicable molecular-based classification for endometrial cancers
- (2015) A Talhouk et al. BRITISH JOURNAL OF CANCER
- POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
- (2015) I. C. van Gool et al. CLINICAL CANCER RESEARCH
- Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer – A pooled analysis of PORTEC 1 and 2 trials
- (2015) Tjalling Bosse et al. EUROPEAN JOURNAL OF CANCER
- Sentinel node biopsy for the management of early stage endometrial cancer: Long-term results of the SENTI-ENDO study
- (2015) Emile Daraï et al. GYNECOLOGIC ONCOLOGY
- Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative
- (2015) Ellen Stelloo et al. MODERN PATHOLOGY
- The impact of lymph vascular space invasion on recurrence and survival in patients with early stage endometrial cancer
- (2013) V. Loizzi et al. EUROPEAN JOURNAL OF CANCER CARE
- Integrated genomic characterization of endometrial carcinoma
- (2013) Gad Getz et al. NATURE
- Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer
- (2011) Saketh R. Guntupalli et al. GYNECOLOGIC ONCOLOGY
- Systematic Pelvic Lymphadenectomy vs No Lymphadenectomy in Early-Stage Endometrial Carcinoma: Randomized Clinical Trial
- (2008) P. B. Panici et al. JNCI-Journal of the National Cancer Institute
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation